Comparative evaluation of AmpliVue HSV 1+2 assay with ELVIS culture for detecting herpes simplex Virus 1 (HSV-1) and HSV-2 in clinical specimens

Paul A. Granato; Brenda R. Alkins; Belinda Yen-Lieberman; Wallace H. Greene; Jessica Connolly; Blake W. Buchan; Nathan A. Ledeboer

doi:10.1128/JCM.01905-15

Comparative evaluation of AmpliVue HSV 1+2 assay with ELVIS culture for detecting herpes simplex Virus 1 (HSV-1) and HSV-2 in clinical specimens

Paul A. Granato, Brenda R. Alkins, Belinda Yen-Lieberman, Wallace H. Greene, Jessica Connolly, Blake W. Buchan, Nathan A. Ledeboer

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Abstract

The AmpliVue HSV 1+2 assay was compared to the ELVIS HSV ID and D3 Typing Culture System for the qualitative detection and differentiation of herpes simplex virus 1 (HSV-1) and HSV-2 DNA in 1,351 cutaneous and mucocutaneous specimens. Compared to ELVIS, AmpliVue had sensitivities of 95.7 and 97.6% for detecting HSV-1 and HSV-2, respectively. Following arbitration of discordant results by an independent molecular method, the AmpliVue assay had a resolved sensitivity and specificity of 99.2 and 99.7%, respectively, for both HSV-1 and HSV-2, whereas ELVIS had a resolved sensitivity of 87.1% for HSV-1 and 84.5% for HSV-2.

Original language	English (US)
Pages (from-to)	3922-3925
Number of pages	4
Journal	Journal of clinical microbiology
Volume	53
Issue number	12
DOIs	https://doi.org/10.1128/JCM.01905-15
State	Published - Dec 2015

All Science Journal Classification (ASJC) codes

Microbiology (medical)

Access to Document

10.1128/JCM.01905-15

Cite this

@article{8a7a9a05a9ce4faa819365e158007811,

title = "Comparative evaluation of AmpliVue HSV 1+2 assay with ELVIS culture for detecting herpes simplex Virus 1 (HSV-1) and HSV-2 in clinical specimens",

abstract = "The AmpliVue HSV 1+2 assay was compared to the ELVIS HSV ID and D3 Typing Culture System for the qualitative detection and differentiation of herpes simplex virus 1 (HSV-1) and HSV-2 DNA in 1,351 cutaneous and mucocutaneous specimens. Compared to ELVIS, AmpliVue had sensitivities of 95.7 and 97.6% for detecting HSV-1 and HSV-2, respectively. Following arbitration of discordant results by an independent molecular method, the AmpliVue assay had a resolved sensitivity and specificity of 99.2 and 99.7%, respectively, for both HSV-1 and HSV-2, whereas ELVIS had a resolved sensitivity of 87.1% for HSV-1 and 84.5% for HSV-2.",

author = "Granato, {Paul A.} and Alkins, {Brenda R.} and Belinda Yen-Lieberman and Greene, {Wallace H.} and Jessica Connolly and Buchan, {Blake W.} and Ledeboer, {Nathan A.}",

note = "Publisher Copyright: {\textcopyright} 2015, American Society for Microbiology.",

year = "2015",

month = dec,

doi = "10.1128/JCM.01905-15",

language = "English (US)",

volume = "53",

pages = "3922--3925",

journal = "Journal of clinical microbiology",

issn = "0095-1137",

publisher = "American Society for Microbiology",

number = "12",

}

TY - JOUR

T1 - Comparative evaluation of AmpliVue HSV 1+2 assay with ELVIS culture for detecting herpes simplex Virus 1 (HSV-1) and HSV-2 in clinical specimens

AU - Granato, Paul A.

AU - Alkins, Brenda R.

AU - Yen-Lieberman, Belinda

AU - Greene, Wallace H.

AU - Connolly, Jessica

AU - Buchan, Blake W.

AU - Ledeboer, Nathan A.

PY - 2015/12

Y1 - 2015/12

N2 - The AmpliVue HSV 1+2 assay was compared to the ELVIS HSV ID and D3 Typing Culture System for the qualitative detection and differentiation of herpes simplex virus 1 (HSV-1) and HSV-2 DNA in 1,351 cutaneous and mucocutaneous specimens. Compared to ELVIS, AmpliVue had sensitivities of 95.7 and 97.6% for detecting HSV-1 and HSV-2, respectively. Following arbitration of discordant results by an independent molecular method, the AmpliVue assay had a resolved sensitivity and specificity of 99.2 and 99.7%, respectively, for both HSV-1 and HSV-2, whereas ELVIS had a resolved sensitivity of 87.1% for HSV-1 and 84.5% for HSV-2.

AB - The AmpliVue HSV 1+2 assay was compared to the ELVIS HSV ID and D3 Typing Culture System for the qualitative detection and differentiation of herpes simplex virus 1 (HSV-1) and HSV-2 DNA in 1,351 cutaneous and mucocutaneous specimens. Compared to ELVIS, AmpliVue had sensitivities of 95.7 and 97.6% for detecting HSV-1 and HSV-2, respectively. Following arbitration of discordant results by an independent molecular method, the AmpliVue assay had a resolved sensitivity and specificity of 99.2 and 99.7%, respectively, for both HSV-1 and HSV-2, whereas ELVIS had a resolved sensitivity of 87.1% for HSV-1 and 84.5% for HSV-2.

UR - http://www.scopus.com/inward/record.url?scp=84947764664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947764664&partnerID=8YFLogxK

U2 - 10.1128/JCM.01905-15

DO - 10.1128/JCM.01905-15

M3 - Article

C2 - 26468497

AN - SCOPUS:84947764664

SN - 0095-1137

VL - 53

SP - 3922

EP - 3925

JO - Journal of clinical microbiology

JF - Journal of clinical microbiology

IS - 12

ER -

Comparative evaluation of AmpliVue HSV 1+2 assay with ELVIS culture for detecting herpes simplex Virus 1 (HSV-1) and HSV-2 in clinical specimens

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this